Food Safety Incidents

Suggestion of therapeutic properties has been detected in Dietary supplement glamorous black deluxe.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Incident Report: Dietary Supplement Safety Concern

On February 12, 2026, a significant food safety incident was reported concerning a dietary supplement identified as a glamorous black deluxe formulation. This incident originated in Brazil and was brought to attention by the Brazilian Health Regulatory Agency, known as ANVISA.

The primary concern surrounding this dietary supplement is the suggestion of therapeutic properties that may not be substantiated by scientific evidence. Such claims can pose potential risks to consumers who may rely on these products for health benefits without proper validation. It is crucial for dietary supplements to undergo rigorous testing and evaluation to ensure their safety and efficacy before being marketed to the public.

Consumers are advised to exercise caution when considering dietary supplements that claim to offer health benefits. It is essential to consult healthcare professionals and rely on products that have been thoroughly evaluated by regulatory authorities. The presence of unverified therapeutic claims can mislead consumers and may lead to adverse health effects.

Regulatory bodies like ANVISA play a vital role in monitoring and controlling the safety of dietary supplements. Ongoing vigilance and adherence to safety standards are necessary to protect public health and ensure that consumers are informed about the products they choose to use.

For further information and updates regarding this incident, consumers are encouraged to stay informed through official health channels and regulatory announcements.

  • Incident: Suggestion of therapeutic properties has been detected in Dietary supplement glamorous black deluxe.
  • Date: 2026-02-12
  • Product: Dietary supplement glamorous black deluxe
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA